Politique publique : Questions médicales fréquentes
Nom anglais: Public Policy
Descriptor UI:D011640
Tree Number:N03.623.500.608
Termes MeSH sélectionnés :
Sleep Initiation and Maintenance Disorders
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Politique publique : Questions médicales les plus fréquentes",
"headline": "Politique publique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Politique publique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-16",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Politique publique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Politiques de régulation sociale",
"url": "https://questionsmedicales.fr/mesh/D011049",
"about": {
"@type": "MedicalCondition",
"name": "Politiques de régulation sociale",
"code": {
"@type": "MedicalCode",
"code": "D011049",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Politique de planification familiale",
"alternateName": "Family Planning Policy",
"url": "https://questionsmedicales.fr/mesh/D016656",
"about": {
"@type": "MedicalCondition",
"name": "Politique de planification familiale",
"code": {
"@type": "MedicalCode",
"code": "D016656",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.214"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Politique de santé",
"alternateName": "Health Policy",
"url": "https://questionsmedicales.fr/mesh/D006291",
"about": {
"@type": "MedicalCondition",
"name": "Politique de santé",
"code": {
"@type": "MedicalCode",
"code": "D006291",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Politique nutritionnelle",
"alternateName": "Nutrition Policy",
"url": "https://questionsmedicales.fr/mesh/D018673",
"about": {
"@type": "MedicalCondition",
"name": "Politique nutritionnelle",
"code": {
"@type": "MedicalCode",
"code": "D018673",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.650"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apports nutritionnels recommandés",
"alternateName": "Recommended Dietary Allowances",
"url": "https://questionsmedicales.fr/mesh/D064167",
"about": {
"@type": "MedicalCondition",
"name": "Apports nutritionnels recommandés",
"code": {
"@type": "MedicalCode",
"code": "D064167",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.650.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Apports nutritionnels recommandés",
"alternateName": "Recommended Dietary Allowances",
"url": "https://questionsmedicales.fr/mesh/D064167",
"about": {
"@type": "MedicalCondition",
"name": "Apports nutritionnels recommandés",
"code": {
"@type": "MedicalCode",
"code": "D064167",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.650.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Contrôle du tabac",
"alternateName": "Tobacco Control",
"url": "https://questionsmedicales.fr/mesh/D000092843",
"about": {
"@type": "MedicalCondition",
"name": "Contrôle du tabac",
"code": {
"@type": "MedicalCode",
"code": "D000092843",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.825"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Politique anti-tabac",
"alternateName": "Smoke-Free Policy",
"url": "https://questionsmedicales.fr/mesh/D061845",
"about": {
"@type": "MedicalCondition",
"name": "Politique anti-tabac",
"code": {
"@type": "MedicalCode",
"code": "D061845",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.825.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prévention du fait de fumer",
"alternateName": "Smoking Prevention",
"url": "https://questionsmedicales.fr/mesh/D000074606",
"about": {
"@type": "MedicalCondition",
"name": "Prévention du fait de fumer",
"code": {
"@type": "MedicalCode",
"code": "D000074606",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.825.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Politique anti-tabac",
"alternateName": "Smoke-Free Policy",
"url": "https://questionsmedicales.fr/mesh/D061845",
"about": {
"@type": "MedicalCondition",
"name": "Politique anti-tabac",
"code": {
"@type": "MedicalCode",
"code": "D061845",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.825.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prévention du fait de fumer",
"alternateName": "Smoking Prevention",
"url": "https://questionsmedicales.fr/mesh/D000074606",
"about": {
"@type": "MedicalCondition",
"name": "Prévention du fait de fumer",
"code": {
"@type": "MedicalCode",
"code": "D000074606",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.825.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Politique publique",
"alternateName": "Public Policy",
"code": {
"@type": "MedicalCode",
"code": "D011640",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Krystyna Kongats",
"url": "https://questionsmedicales.fr/author/Krystyna%20Kongats",
"affiliation": {
"@type": "Organization",
"name": "School of Public Health, University of Alberta, Edmonton Clinic Health Academy, Edmonton, Alberta, Canada."
}
},
{
"@type": "Person",
"name": "Jennifer Ann McGetrick",
"url": "https://questionsmedicales.fr/author/Jennifer%20Ann%20McGetrick",
"affiliation": {
"@type": "Organization",
"name": "School of Public Health, University of Alberta, Edmonton Clinic Health Academy, Edmonton, Alberta, Canada."
}
},
{
"@type": "Person",
"name": "Kim D Raine",
"url": "https://questionsmedicales.fr/author/Kim%20D%20Raine",
"affiliation": {
"@type": "Organization",
"name": "School of Public Health, University of Alberta, Edmonton Clinic Health Academy, Edmonton, Alberta, Canada."
}
},
{
"@type": "Person",
"name": "Sonja Grelle",
"url": "https://questionsmedicales.fr/author/Sonja%20Grelle",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Psychology, Ruhr University Bochum."
}
},
{
"@type": "Person",
"name": "Wilhelm Hofmann",
"url": "https://questionsmedicales.fr/author/Wilhelm%20Hofmann",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Psychology, Ruhr University Bochum."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Transitional Urology in Korea: Initial Insights Through a Cross-Sectional Study.",
"datePublished": "2024-06-30",
"url": "https://questionsmedicales.fr/article/38956776",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5213/inj.2448186.093"
}
},
{
"@type": "ScholarlyArticle",
"name": "Derivation and Initial Validation of the Utility Function for the Hearing Utility Measure (HUM).",
"datePublished": "2024-06-20",
"url": "https://questionsmedicales.fr/article/38899833",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/lary.31590"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuropathy of diabetes following initiation of a low-carbohydrate diet: Case report.",
"datePublished": "2024-06-14",
"url": "https://questionsmedicales.fr/article/38983905",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.obpill.2024.100115"
}
},
{
"@type": "ScholarlyArticle",
"name": "Three-step clinical simulation model: An initiative to guide its implementation.",
"datePublished": "2024-06-13",
"url": "https://questionsmedicales.fr/article/38856674",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5546/aap.2024-10343.eng"
}
},
{
"@type": "ScholarlyArticle",
"name": "Unveiling the Path: A Qualitative Study on the Initial Sexual Experiences of Cambodian Adolescents.",
"datePublished": "2024-06-12",
"url": "https://questionsmedicales.fr/article/38864286",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10436596241259199"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Politique (principe)",
"item": "https://questionsmedicales.fr/mesh/D057766"
},
{
"@type": "ListItem",
"position": 4,
"name": "Politiques de régulation sociale",
"item": "https://questionsmedicales.fr/mesh/D011049"
},
{
"@type": "ListItem",
"position": 5,
"name": "Politique publique",
"item": "https://questionsmedicales.fr/mesh/D011640"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Politique publique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Politique publique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Politique publique",
"description": "Comment évaluer l'impact d'une politique publique en santé ?\nQuels outils sont utilisés pour le diagnostic des politiques ?\nQuelles sont les méthodes d'analyse des politiques publiques ?\nComment identifier les besoins de santé dans une communauté ?\nQuel rôle joue la recherche dans le diagnostic des politiques ?",
"url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=998#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Politique publique",
"description": "Quels symptômes indiquent un échec de la politique publique ?\nComment mesurer les symptômes de l'inefficacité des politiques ?\nQuels indicateurs de santé révèlent des problèmes systémiques ?\nComment les symptômes sociaux affectent-ils la santé publique ?\nQuels symptômes peuvent signaler un besoin de réforme ?",
"url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=998#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Politique publique",
"description": "Quelles stratégies de prévention sont efficaces en politique publique ?\nComment évaluer l'efficacité des programmes de prévention ?\nQuels obstacles à la prévention sont souvent rencontrés ?\nComment les politiques publiques peuvent-elles promouvoir la prévention ?\nQuel rôle joue l'éducation dans la prévention des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=998#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Politique publique",
"description": "Comment les politiques influencent-elles les traitements disponibles ?\nQuels traitements sont souvent négligés par les politiques publiques ?\nComment évaluer l'efficacité des traitements en politique publique ?\nQuel est l'impact des politiques sur les traitements préventifs ?\nComment les politiques de santé affectent-elles les traitements psychologiques ?",
"url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=998#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Politique publique",
"description": "Quelles complications peuvent résulter d'une mauvaise politique de santé ?\nComment les complications de santé sont-elles liées aux politiques publiques ?\nQuels sont les effets à long terme d'une politique de santé défaillante ?\nComment prévenir les complications liées aux politiques de santé ?\nQuel rôle jouent les données dans la prévention des complications ?",
"url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=998#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Politique publique",
"description": "Quels facteurs de risque sont souvent négligés par les politiques ?\nComment les politiques peuvent-elles réduire les facteurs de risque ?\nQuel impact a l'environnement sur les facteurs de risque ?\nComment les politiques de santé abordent-elles les facteurs de risque ?\nQuels sont les facteurs de risque liés aux comportements ?",
"url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=998#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'impact d'une politique publique en santé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact se mesure par des indicateurs de santé, des études d'impact et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic des politiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes, des analyses statistiques et des études de cas sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quelles sont les méthodes d'analyse des politiques publiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les méthodes incluent l'analyse qualitative, quantitative et l'analyse coût-bénéfice."
}
},
{
"@type": "Question",
"name": "Comment identifier les besoins de santé dans une communauté ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des enquêtes, des focus groups et l'analyse des données de santé existantes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la recherche dans le diagnostic des politiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La recherche fournit des données probantes pour orienter les décisions politiques et évaluer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un échec de la politique publique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inégalités de santé croissantes et une augmentation des maladies évitables peuvent indiquer un échec."
}
},
{
"@type": "Question",
"name": "Comment mesurer les symptômes de l'inefficacité des politiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "En analysant les taux de morbidité, mortalité et l'accès aux soins de santé."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de santé révèlent des problèmes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les taux de vaccination, d'obésité et de maladies chroniques sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sociaux affectent-ils la santé publique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes comme la pauvreté et le chômage aggravent les conditions de santé et l'accès aux soins."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent signaler un besoin de réforme ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une hausse des plaintes des citoyens et des résultats de santé dégradés peuvent signaler ce besoin."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces en politique publique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de sensibilisation, les programmes de vaccination et l'éducation à la santé."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des programmes de prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études d'impact, des indicateurs de santé et des analyses de coûts."
}
},
{
"@type": "Question",
"name": "Quels obstacles à la prévention sont souvent rencontrés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le manque de financement, l'accès limité aux soins et la désinformation sont des obstacles majeurs."
}
},
{
"@type": "Question",
"name": "Comment les politiques publiques peuvent-elles promouvoir la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "En intégrant des programmes de prévention dans les systèmes de santé et en finançant des initiatives."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation dans la prévention des maladies ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sensibilise la population aux comportements sains et aux risques de maladies."
}
},
{
"@type": "Question",
"name": "Comment les politiques influencent-elles les traitements disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les politiques déterminent le financement, l'accès et les protocoles de traitement en santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont souvent négligés par les politiques publiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements pour les maladies rares et les soins palliatifs sont souvent sous-financés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des traitements en politique publique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études cliniques, des revues systématiques et des analyses de coût-efficacité."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des politiques sur les traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les politiques favorisent l'accès aux vaccinations et dépistages, réduisant ainsi les maladies."
}
},
{
"@type": "Question",
"name": "Comment les politiques de santé affectent-elles les traitements psychologiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles influencent le financement et l'accès aux soins de santé mentale, souvent négligés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une mauvaise politique de santé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inégalités de santé, une augmentation des maladies chroniques et un accès limité aux soins."
}
},
{
"@type": "Question",
"name": "Comment les complications de santé sont-elles liées aux politiques publiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des politiques inefficaces peuvent aggraver les conditions de santé et limiter l'accès aux traitements."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme d'une politique de santé défaillante ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une augmentation des coûts de santé, une détérioration de la santé publique et des inégalités croissantes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux politiques de santé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "En évaluant régulièrement les politiques et en adaptant les programmes aux besoins de la population."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les données dans la prévention des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les données aident à identifier les problèmes, à évaluer les politiques et à orienter les interventions."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont souvent négligés par les politiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déterminants sociaux de la santé, comme la pauvreté et l'éducation, sont souvent sous-estimés."
}
},
{
"@type": "Question",
"name": "Comment les politiques peuvent-elles réduire les facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "En promouvant des environnements sains, l'éducation et l'accès aux soins préventifs."
}
},
{
"@type": "Question",
"name": "Quel impact a l'environnement sur les facteurs de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement pollué ou peu sûr augmente les risques de maladies et affecte la santé publique."
}
},
{
"@type": "Question",
"name": "Comment les politiques de santé abordent-elles les facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles intègrent des stratégies de prévention et d'éducation pour réduire les risques de maladies."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque liés aux comportements ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'alimentation malsaine et le manque d'activité physique sont des facteurs clés."
}
}
]
}
]
}
In Korea, the field of transitional urology (TU) is in its nascent stages, with its introduction only beginning. This study aims to evaluate the existing state of TU prior to implementing a transition...
From June 1, 2021 to May 31, 2023, clinical data were retrospectively collected for patients who visited the adult urology or pediatric urology outpatient departments of this hospital and were aged 10...
During a 2-year period, a total of 1,484 patients received outpatient care for diseases in TU field. The most prevalent diseases were hypospadias (40.4%), spinal bifida (37.3%), and congenital uretera...
TU in Korea is in its nascent stage, with a significant gap in the initiation and completion of transitional care for patients with congenital urologic conditions. Early initiation and active engageme...
The Hearing Utility Measure (HUM) is a replacement hearing attribute for the Health Utilities Index, Mark 3 (HUI-3) designed to improve the responsiveness of utility estimates to changes in hearing-re...
Residents of Ontario, Canada, aged ≥18 years participated in standard gamble and visual analogue scale exercises. Valuations for levels (response options) within each domain, and for each domain relat...
A total of 126 respondents participated (mean age 39.2, range 18-85 years, 53% female [67/126]). The utility function performed well in the estimation of directly elicited utilities (mean difference 0...
The new hearing attribute is capable of measuring variations in hearing utility not captured by the legacy HUI-3, especially near the ceiling of hearing function. These findings justify its applicatio...
3 Laryngoscope, 2024....
This case study portrays an unusual case of treatment-induced neuropathy of diabetes (TIND) in a patient with uncontrolled type 2 diabetes (T2D) who achieved rapid improvement in glucose control prima...
The initial intervention included a low-carbohydrate diet, metformin, and a continuous glucose monitor (CGM). Semaglutide was added after seven days....
His glycemia was within the target range within three weeks. Four weeks after initiation of therapy, he developed TIND symptoms consisting of burning, tightness, and numbness of bilateral feet along w...
Whereas TIND is commonly associated with the use of insulin or sulfonylureas, this study adds evidence to the paucity of literature regarding TIND precipitated by dietary intervention....
The design and implementation of simulation-based learning is a major institutional challenge. It involves planning the activity and preparing information and resources, as well as accompanying and gu...
There still remains a significant gap in understanding the sexual and reproductive health challenges faced by adolescents, particularly in the context of early sexual activity, teenage pregnancy, and ...
A descriptive qualitative research design was used. Thirty Cambodian adolescents were interviewed from March to June 202 and data were analyzed using thematic analysis....
Participants met their sexual partners in school and through friendships and social networking sites. Their motivations for sexual activities ranged from intrinsic desires to influences of inebriation...
The findings suggest the need for educational interventions that address substance use; promote safe behavior, consensual conduct, open communication, and mutual respect; and provide coping strategies...
Evidence is accumulating on the impact of previous adverse pregnancy events on future fertility in natural conceptions. However, there is limited knowledge on whether an ectopic pregnancy (EP) or misc...
To investigate the effect of first IVF outcomes: miscarriage, EP, and no pregnancy, on the second cycle outcomes based on a freeze-all strategy....
Retrospective cohort study....
University-affiliated IVF center....
This study involved 16,479 women who had undergone 2 complete frozen embryo transfers (FET) and were classified into 3 groups based on first FET outcomes....
None....
Live birth rate (LBR)....
After correcting for confounders, the LBR after the second FET was similar between women who suffered an EP and those who had no pregnancies in their first FET cycles (adjusted OR (aOR), 1.03; 95% con...
Women who had a miscarriage in the first FET cycle had a higher chance of achieving live births in the subsequent treatment cycle when compared to those who had no pregnancy in the initial cycle. Furt...
Pericardial effusion, a clinical condition characterized by an abnormal accumulation of fluid in the pericardial cavity, has multiple etiological factors. One of the prominent causes is malignant effu...
The InBIO Barcoding Initiative (IBI) Orthoptera dataset contains records of 420 specimens covering all the eleven Orthoptera families occurring in Portugal. Specimens were collected in continental Por...
DNA barcodes of 54 taxa were made public for the first time at the Barcode of Life Data System (BOLD). Furthermore, the submitted sequences were found to cluster in 129 BINs (Barcode Index Numbers), 3...
There is limited information on the mode of arrhythmia initiation in idiopathic ventricular fibrillation (IVF). A non-pause-dependent mechanism has been suggested to be the rule....
The aim of this study was to assess the mode and characteristics of initiation of polymorphic ventricular tachycardia (PVT) in patients with short or long-coupled PVT/IVF included in THESIS (THerapy E...
We reviewed the initiation of 410 episodes of ≥1 PVT triplet in 180 patients (58.3% females; age 39.6 ± 13.6 years) with IVF. The incidence of pause-dependency arrhythmia initiation (prolongation by >...
Most arrhythmias (n = 295; 72%) occurred during baseline supraventricular rhythm without ambient premature ventricular complexes (PVCs), whereas 106 (25.9%) occurred during baseline rhythm including P...
Pause-dependent initiation occurred in more than a quarter of arrhythmic episodes in IVF patients. PVCs having long (between 350 and 500 ms) and very long (>500 ms) coupling intervals were observed at...
Acute pancreatitis is a rare manifestation of acute myeloid leukemia which can be a presentation at the initial diagnosis or during or after the onset of the disease. Acute myeloid leukemia occurs due...